Skip to content
10-Q

Quarterly Report

Aprea Therapeutics, Inc. APRE

0001104659-25-109867

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 6.31M sh
Shares Diluted Q3 2025 · Sep 30, 2025 6.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 6.15M sh
Shares Diluted Q3 2025 · Sep 30, 2024 5.94M sh
Shares Diluted Q3 2025 · Sep 30, 2024 5.36M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$9.93M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$10.05M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $13.72M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $22.85M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $26.25M
Stockholders Equity Q3 2025 · Sep 30, 2025 $10.91M
Stockholders Equity Q3 2025 · Jun 30, 2025 $13.41M
Stockholders Equity Q3 2025 · Mar 31, 2025 $15.55M
Stockholders Equity Q3 2025 · Dec 31, 2024 $19.31M
Stockholders Equity Q3 2025 · Sep 30, 2024 $21.95M
Stockholders Equity Q3 2025 · Jun 30, 2024 $25.56M
Stockholders Equity Q3 2025 · Mar 31, 2024 $28.92M
Stockholders Equity Q3 2025 · Dec 31, 2023 $16.95M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.68M
Current Liabilities Q3 2025 · Dec 31, 2024 $3.36M
Current Assets Q3 2025 · Sep 30, 2025 $13.94M
Current Assets Q3 2025 · Dec 31, 2024 $23.58M
Total Assets Q3 2025 · Sep 30, 2025 $14.32M
Total Assets Q3 2025 · Dec 31, 2024 $23.98M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.47
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.65
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.64
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.88
Eps Basic Q3 2025 · Sep 30, 2025 −$0.47
Eps Basic Q3 2025 · Sep 30, 2025 −$1.65
Eps Basic Q3 2025 · Sep 30, 2024 −$0.64
Eps Basic Q3 2025 · Sep 30, 2024 −$1.88
Sga Expense Q3 2025 · Sep 30, 2025 $1.48M
Sga Expense Q3 2025 · Sep 30, 2025 $4.84M
Sga Expense Q3 2025 · Sep 30, 2024 $1.61M
Sga Expense Q3 2025 · Sep 30, 2024 $5.39M
Net Income Q3 2025 · Sep 30, 2025 −$2.97M
Net Income Q3 2025 · Sep 30, 2025 −$10.14M
Net Income Q3 2025 · Jun 30, 2025 −$3.24M
Net Income Q3 2025 · Mar 31, 2025 −$3.93M
Net Income Q3 2025 · Sep 30, 2024 −$3.78M
Net Income Q3 2025 · Sep 30, 2024 −$10.06M
Net Income Q3 2025 · Jun 30, 2024 −$3.47M
Net Income Q3 2025 · Mar 31, 2024 −$2.81M
Operating Income Q3 2025 · Sep 30, 2025 −$3.12M
Operating Income Q3 2025 · Sep 30, 2025 −$10.59M
Operating Income Q3 2025 · Sep 30, 2024 −$4.1M
Operating Income Q3 2025 · Sep 30, 2024 −$11.09M
Capex Q3 2025 · Sep 30, 2024 $15.48K